Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Arine

Explore full profile

Optimizes medication to ensure each patient is on the safest, most effective therapy for their unique health needs

San Francisco, United StatesFounded 2017Health Tech & Medtech
Valuation $100–250M Last recorded · 2025
Revenue $10–50M Latest reported FY
Headcount 100–500 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Arine and the history behind them.

About Arine

Arine.io is a healthcare technology startup focused on optimizing medication management to improve patient outcomes and reduce healthcare costs. The company operates in the healthcare sector, specifically targeting older adults and individuals with poor health status who require complex medication regimens. Arine's platform leverages data-driven, predictive analytics and robust evidence to provide personalized medication therapy management (MTM). This approach ensures that medications are used safely and effectively, tailored to each patient's unique health profile.

Arine's primary clients include healthcare providers, insurance companies, and health plans that aim to enhance the quality of care they deliver. By partnering with these organizations, Arine helps improve their performance metrics, such as CAHPS (Consumer Assessment of Healthcare Providers and Systems) ratings and Star ratings, which are critical indicators of patient satisfaction and care quality.

The company's business model revolves around a subscription-based service where healthcare organizations pay for access to Arine's platform and its suite of tools. These tools include comprehensive medication management, medication intelligence, and medication optimization services. Arine generates revenue by providing these services, which help their clients achieve better health outcomes for their patients, thereby reducing overall healthcare costs.

Arine's innovative use of technology in medication management positions it as a leader in the field of personalized medicine. By ensuring that patients receive the right medications at the right doses, Arine not only enhances patient health but also contributes to the financial efficiency of healthcare systems.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2017
Headquarters
San Francisco, United States
Employees
361
Open positions
8
Dealroom signal
39.5/100
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Core AI, Hard Tech, AI Applications
Technology
Artificial Intelligence
Business model
SaaS
Client focus
b2b

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES COther financing Jun 2025 $30M $120M Kaiser Permanente Ventures · Town Hall Ventures ↗
DEBTDebt Aug 2022 $11M — Undisclosed ↗
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023
2022 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Arine website traffic

Latest recorded traffic for Arine is 9K monthly website visits, up 12.5% over the last three months. Arine's team grew 268.4% over the past year.

Latest monthly visits9K 3-month web change+12.5% 1-year team growth+268.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A7 investors entered at this stage

  • 111° West Capital
  • Katalyst Ventures
  • Magellan Health Services
  • SCAN Group
  • Super Capital Group
  • New Leaf Venture Partners
  • MBX Capital

Series B and later2 investors entered at this stage

  • Town Hall Ventures
  • Kaiser Permanente Ventures
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States99.1%
🇨🇦 Canada0.5%
🇩🇪 Germany0.5%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Arine on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Arine’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.